News

Nitisinone, a drug that is already used to treat two genetic diseases, could be repurposed to control the spread of malaria, ...
Pacira BioSciences PCRX announced that it has dosed the first patient in a mid-stage study of pipeline candidate PCRX-201 ...
Here are 15 data management and data analytics technology companies, part of the 2025 CRN AI 100, that are playing an ...
loading vector tiles in Leaflet could only be done with the Leaflet.MapboxVectorTile or the Hoverboard plugin, but neither of those works with Leaflet 1.0.0 (or greater). VectorGrid leverages the ...
The FDA has fully approved larotrectinib for adult and pediatric patients with solid tumors that harbor an NTRK gene fusion.
Heaviest known elementary particles and their antimatter counterparts are detected after nuclear smash-ups at the Large ...
Superconductivity—the ability of some materials to conduct electricity with no energy loss—holds immense promise for new ...
Several transcription factors in developing neurons exhibit broad-to-restricted expression patterns, but the relevance of ...
T1 and DRX have both confirmed their playoff advancement during Week 3 of the VCT Pacific Stage 1, with decisive victories ...
AI outperformed clinicians and almost matched hs-TnT testing, but one expert questioned if this is where it’s needed most.
Se2 have become a less-expensive photovoltaic technology than crystalline Si wafer solar cells. Still, their efficiencies are ...
Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to study ...